$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2023 Q1 Form 10-Q Financial Statement

#000162828023002413 Filed on February 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $146.3M $62.55M $27.44M
YoY Change -3.65% 127.95% 28.82%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $25.16M $22.65M $24.59M
YoY Change -25.7% -7.89% 184.3%
% of Gross Profit
Research & Development $74.88M $83.70M $63.60M
YoY Change 1.46% 31.61% 82.38%
% of Gross Profit
Depreciation & Amortization $2.200M $2.300M $2.100M
YoY Change -15.19% 9.52% 50.0%
% of Gross Profit
Operating Expenses $98.10M $104.7M $90.76M
YoY Change -11.02% 15.34% 100.09%
Operating Profit $48.17M -$42.13M -$63.32M
YoY Change 15.91% -33.46%
Interest Expense $5.057M -$167.0K $1.156M
YoY Change 379.79% -114.45% -46.73%
% of Operating Profit 10.5%
Other Income/Expense, Net -$489.0K $340.0K $449.0K
YoY Change -127.8% -24.28% -61.06%
Pretax Income $47.68M -$41.79M -$62.87M
YoY Change 7.46% -33.53% 203.29%
Income Tax $0.00 $17.00K $0.00
% Of Pretax Income 0.0%
Net Earnings $48.68M -$41.33M -$62.87M
YoY Change 9.71% -34.27% 203.26%
Net Earnings / Revenue 33.28% -66.07% -229.13%
Basic Earnings Per Share $0.46 -$0.39 -$0.60
Diluted Earnings Per Share $0.45 -$0.39 -$0.60
COMMON SHARES
Basic Shares Outstanding 108.3M shares 106.0M shares 104.5M
Diluted Shares Outstanding 108.1M shares 106.0M shares 104.5M

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $481.0M $501.8M $217.6M
YoY Change 19.68% 130.63% -3.68%
Cash & Equivalents $135.0M $202.2M $91.59M
Short-Term Investments $346.0M $299.6M $126.0M
Other Short-Term Assets $14.44M $25.19M $7.994M
YoY Change 0.12% 215.09% -14.96%
Inventory
Prepaid Expenses $9.935M $8.412M
Receivables $69.43M $39.57M $150.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $574.8M $575.0M $338.3M
YoY Change 37.64% 69.98% 4.5%
LONG-TERM ASSETS
Property, Plant & Equipment $185.2M $147.3M $52.30M
YoY Change 159.91% 181.65% 55.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $78.83M $115.8M $217.6M
YoY Change -60.89% -46.79% 96.19%
Other Assets $210.0K $210.0K $273.0K
YoY Change -23.64% -23.08% -9.0%
Total Long-Term Assets $316.5M $316.5M $300.3M
YoY Change 10.68% 5.4% 70.99%
TOTAL ASSETS
Total Short-Term Assets $574.8M $575.0M $338.3M
Total Long-Term Assets $316.5M $316.5M $300.3M
Total Assets $891.3M $891.5M $638.5M
YoY Change 26.68% 39.61% 27.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.556M $796.0K $4.068M
YoY Change -9.87% -80.43% -15.25%
Accrued Expenses $39.55M $48.17M $24.31M
YoY Change 30.17% 98.15% 80.09%
Deferred Revenue $29.84M $66.28M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $87.15M $122.0M $137.0M
YoY Change -37.24% -10.96% 445.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $339.1M $373.1M $128.9M
YoY Change 201.51% 189.35% 554.55%
Total Long-Term Liabilities $339.1M $373.1M $128.9M
YoY Change 201.51% 189.35% 555.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $87.15M $122.0M $137.0M
Total Long-Term Liabilities $339.1M $373.1M $128.9M
Total Liabilities $426.2M $495.1M $266.0M
YoY Change 69.59% 86.15% 493.7%
SHAREHOLDERS EQUITY
Retained Earnings -$813.4M -$862.1M
YoY Change
Common Stock $1.261B $1.239B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $446.8M $377.0M $372.6M
YoY Change
Total Liabilities & Shareholders Equity $891.3M $891.5M $638.5M
YoY Change 26.68% 39.61% 27.89%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income $48.68M -$41.33M -$62.87M
YoY Change 9.71% -34.27% 203.26%
Depreciation, Depletion And Amortization $2.200M $2.300M $2.100M
YoY Change -15.19% 9.52% 50.0%
Cash From Operating Activities -$31.67M -$75.52M -$61.35M
YoY Change -150.49% 23.1% 57.62%
INVESTING ACTIVITIES
Capital Expenditures $27.31M $38.91M -$5.778M
YoY Change -674.79% -773.43% -235.28%
Acquisitions
YoY Change
Other Investing Activities -$8.751M -$41.78M -$27.61M
YoY Change -86.54% 51.35% -180.25%
Cash From Investing Activities -$36.07M -$80.69M -$33.39M
YoY Change -48.3% 141.71% -210.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 520.0K $250.6M 1.885M
YoY Change -71.83% 13193.16% -63.05%
NET CHANGE
Cash From Operating Activities -31.67M -$75.52M -61.35M
Cash From Investing Activities -36.07M -$80.69M -33.39M
Cash From Financing Activities 520.0K $250.6M 1.885M
Net Change In Cash -67.22M $94.37M -92.85M
YoY Change 1197.86% -201.64% 2435.42%
FREE CASH FLOW
Cash From Operating Activities -$31.67M -$75.52M -$61.35M
Capital Expenditures $27.31M $38.91M -$5.778M
Free Cash Flow -$58.98M -$114.4M -$55.57M
YoY Change -187.41% 105.92% 28.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000879407
CY2022Q4 dei Local Phone Number
LocalPhoneNumber
304-3400
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 dei Document Type
DocumentType
10-Q
CY2022Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 dei Entity File Number
EntityFileNumber
001-38042
CY2022Q4 dei Entity Registrant Name
EntityRegistrantName
ARROWHEAD PHARMACEUTICALS, INC.
CY2022Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0408024
CY2022Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
177 E. Colorado Blvd
CY2022Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2022Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Pasadena
CY2022Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91105
CY2022Q4 dei City Area Code
CityAreaCode
626
CY2022Q4 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022Q4 dei Trading Symbol
TradingSymbol
ARWR
CY2022Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
108310163 shares
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202249000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108005000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39568000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1410000 usd
CY2022Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
299582000 usd
CY2022Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
268391000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8412000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7289000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
25188000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
20204000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
574999000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
405299000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
147314000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
110297000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11537000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11962000 usd
CY2022Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
115774000 usd
CY2022Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
105872000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41655000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58291000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
210000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
218000 usd
CY2022Q4 us-gaap Assets
Assets
891489000 usd
CY2022Q3 us-gaap Assets
Assets
691939000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
796000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2868000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48174000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46856000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4094000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12251000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2664000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2776000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
66281000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
74099000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
122009000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
138850000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79470000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78800000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
40789000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
55950000 usd
CY2022Q4 arwr Royalties Liability Noncurrent
RoyaltiesLiabilityNoncurrent
252849000 usd
CY2022Q3 arwr Royalties Liability Noncurrent
RoyaltiesLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
373108000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
134750000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
106140000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106140000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105960000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105960000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
199000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
198000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1239178000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1219213000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-258000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-136000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-862080000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-820755000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
377039000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
398520000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
19333000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
19819000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
396372000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
418339000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
891489000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
691939000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62546000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27439000 usd
CY2022Q4 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
83695000 usd
CY2021Q4 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
65765000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20985000 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24995000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
104680000 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
90760000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-42134000 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-63321000 usd
CY2022Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-167000 usd
CY2021Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1156000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
507000 usd
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-707000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
340000 usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
449000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-41794000 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62872000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-41811000 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-62872000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-486000 usd
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-41325000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-62872000 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106039000 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
104534000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106039000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
104534000 shares
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-122000 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-39000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-41933000 usd
CY2021Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-62911000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
408822000 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24504000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2145000 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-39000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-62872000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
372560000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
418339000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19390000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
576000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-122000 usd
CY2022Q4 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
486000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-41325000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
396372000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-41811000 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-62872000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
19390000 usd
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
24504000 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2689000 usd
CY2021Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2573000 usd
CY2022Q4 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-690000 usd
CY2021Q4 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
280000 usd
CY2022Q4 arwr Non Cash Interest Expense Liability Related To Sale Of Future Royalties
NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties
2849000 usd
CY2021Q4 arwr Non Cash Interest Expense Liability Related To Sale Of Future Royalties
NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties
0 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
38157000 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10105000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10529000 usd
CY2021Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
450000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2072000 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5389000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7203000 usd
CY2021Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2290000 usd
CY2022Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-22979000 usd
CY2021Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-27439000 usd
CY2022Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
559000 usd
CY2021Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
230000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75516000 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61308000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38911000 usd
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5778000 usd
CY2022Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
111199000 usd
CY2021Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
65875000 usd
CY2022Q4 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
69416000 usd
CY2021Q4 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
38268000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80694000 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33385000 usd
CY2022Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
576000 usd
CY2021Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1885000 usd
CY2022Q4 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
250000000 usd
CY2021Q4 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
250576000 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1885000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
94366000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-92808000 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-122000 usd
CY2021Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-39000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
108005000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
184434000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
202249000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
91587000 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202200000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7300000 usd
CY2022Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
299600000 usd
CY2022Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
115800000 usd
CY2022Q4 arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
135300000 usd
CY2022Q4 arwr Development Regulatory And Sales Milestones Payments
DevelopmentRegulatoryAndSalesMilestonesPayments
4100000000 usd
CY2022Q4 arwr Computers Software Office Equipment And Furniture Gross
ComputersSoftwareOfficeEquipmentAndFurnitureGross
2182000 usd
CY2022Q3 arwr Computers Software Office Equipment And Furniture Gross
ComputersSoftwareOfficeEquipmentAndFurnitureGross
2182000 usd
CY2022Q4 us-gaap Land
Land
2996000 usd
CY2022Q3 us-gaap Land
Land
2996000 usd
CY2022Q4 arwr Research Equipment Gross
ResearchEquipmentGross
43739000 usd
CY2022Q3 arwr Research Equipment Gross
ResearchEquipmentGross
38283000 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
42017000 usd
CY2022Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
42017000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
90215000 usd
CY2022Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
56373000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
181149000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
141851000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33835000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31554000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
147314000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
110297000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2300000 usd
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2100000 usd
CY2022Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
299582000 usd
CY2022Q4 arwr Debt Securities Held To Maturity Accumulated Unrecognized Gain Current
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedGainCurrent
0 usd
CY2022Q4 arwr Debt Securities Held To Maturity Accumulated Unrecognized Loss Current
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedLossCurrent
2644000 usd
CY2022Q4 us-gaap Debt Securities Held To Maturity Fair Value Current
DebtSecuritiesHeldToMaturityFairValueCurrent
296938000 usd
CY2022Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2022Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
115774000 usd
CY2022Q4 arwr Debt Securities Held To Maturity Accumulated Unrecognized Gain Noncurrent
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedGainNoncurrent
0 usd
CY2022Q4 arwr Debt Securities Held To Maturity Accumulated Unrecognized Loss Noncurrent
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedLossNoncurrent
4440000 usd
CY2022Q4 us-gaap Debt Securities Held To Maturity Fair Value Noncurrent
DebtSecuritiesHeldToMaturityFairValueNoncurrent
111334000 usd
CY2022Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
268391000 usd
CY2022Q3 arwr Debt Securities Held To Maturity Accumulated Unrecognized Gain Current
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedGainCurrent
0 usd
CY2022Q3 arwr Debt Securities Held To Maturity Accumulated Unrecognized Loss Current
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedLossCurrent
3661000 usd
CY2022Q3 us-gaap Debt Securities Held To Maturity Fair Value Current
DebtSecuritiesHeldToMaturityFairValueCurrent
264730000 usd
CY2022Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
105872000 usd
CY2022Q3 arwr Debt Securities Held To Maturity Accumulated Unrecognized Gain Noncurrent
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedGainNoncurrent
0 usd
CY2022Q3 arwr Debt Securities Held To Maturity Accumulated Unrecognized Loss Noncurrent
DebtSecuritiesHeldToMaturityAccumulatedUnrecognizedLossNoncurrent
5569000 usd
CY2022Q3 us-gaap Debt Securities Held To Maturity Fair Value Noncurrent
DebtSecuritiesHeldToMaturityFairValueNoncurrent
100303000 usd
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1275000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1700000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700000 usd
CY2022Q4 arwr Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
3462000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11537000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106140000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
106140000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105960000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105960000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 arwr Tax Increment Financing Award
TaxIncrementFinancingAward
16000000 usd
CY2021Q4 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
2500000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41655000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58291000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2664000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2776000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79470000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78800000 usd
CY2022Q4 us-gaap Lease Cost
LeaseCost
2812000 usd
CY2022 us-gaap Lease Cost
LeaseCost
1456000 usd
CY2022Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 usd
CY2021Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4470000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8094000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11800000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12138000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11297000 usd
CY2022Q4 arwr Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
102813000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
150612000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
68478000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
82134000 usd
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
1331000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1023000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M24D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2625776 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.02
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2625776 shares
CY2022Q4 arwr Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstanding
6589957 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2721384 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.73
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
13875 shares
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
45.57
CY2022Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
81733 shares
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.04
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
61867396 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2346710 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.83
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
60525256 usd

Files In Submission

Name View Source Status
0001628280-23-002413-index-headers.html Edgar Link pending
0001628280-23-002413-index.html Edgar Link pending
0001628280-23-002413.txt Edgar Link pending
0001628280-23-002413-xbrl.zip Edgar Link pending
arwr-20221231.htm Edgar Link pending
arwr-20221231.xsd Edgar Link pending
arwr-20221231xexx311.htm Edgar Link pending
arwr-20221231xexx312.htm Edgar Link pending
arwr-20221231xexx321.htm Edgar Link pending
arwr-20221231xexx322.htm Edgar Link pending
arwr-20221231_cal.xml Edgar Link unprocessable
arwr-20221231_def.xml Edgar Link unprocessable
arwr-20221231_lab.xml Edgar Link unprocessable
arwr-20221231_pre.xml Edgar Link unprocessable
arwr-20221231_htm.xml Edgar Link completed
exhibit101.htm Edgar Link pending
exhibit31.htm Edgar Link pending
exhibit32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable